Search

Your search keyword '"Wang Rong"' showing total 42 results

Search Constraints

Start Over You searched for: Author "Wang Rong" Remove constraint Author: "Wang Rong" Topic moyamoya disease Remove constraint Topic: moyamoya disease
42 results on '"Wang Rong"'

Search Results

1. Angioarchitectural Factors Associated with Postoperative Cerebral Infarction in Ischemic Moyamoya Disease.

2. Clinical Features and Long-Term Outcomes of Unilateral Moyamoya Disease.

3. Circulating immune cell landscape and T‐cell abnormalities in patients with moyamoya disease.

4. Nonalcoholic fatty liver disease is an independent risk factor for ischemic stroke after revascularization in patients with Moyamoya disease: a prospective cohort study.

5. Risk factors for postoperative ischemic complications in pediatric moyamoya disease.

6. The prognostic nutrition index is a predictor for long-term outcomes after revascularization in adult moyamoya disease.

7. Metabolomic signatures associated with pathological angiogenesis in moyamoya disease.

8. Integrated analysis of the association between methionine cycle and risk of moyamoya disease.

9. Association between DIAPH1 variant and posterior circulation involvement with Moyamoya disease.

10. RNA profiling of sEV (small extracellular vesicles)/exosomes reveals biomarkers and vascular endothelial dysplasia with moyamoya disease.

11. Correlation of Serum N-Acetylneuraminic Acid with the Risk of Moyamoya Disease.

12. Serum Kynurenic Acid and Kynurenine Are Negatively Associated with the Risk of Adult Moyamoya Disease.

13. Changes of cerebral cortical structure and cognitive dysfunction in "healthy hemisphere" after stroke: a study about cortical complexity and sulcus patterns in bilateral ischemic adult moyamoya disease.

14. Regional cerebral perfusion and ischemic status after standard superficial temporal artery-middle cerebral artery (STA-MCA) bypass surgery in ischemic cerebrovascular disease.

15. Hyperhomocysteinemia is a risk factor for postoperative ischemia in adult patients with moyamoya disease.

16. Intraoperative local hemodynamic quantitative analysis of direct revascularization in patients with moyamoya disease.

17. Impairments in brain perfusion, executive control network, topological characteristics, and neurocognition in adult patients with asymptomatic Moyamoya disease.

18. Intraoperative transit-time ultrasonography combined with FLOW800 predicts the occurrence of cerebral hyperperfusion syndrome after direct revascularization of Moyamoya disease: a preliminary study.

19. High variance of intraoperative blood pressure predicts early cerebral infarction after revascularization surgery in patients with Moyamoya disease.

20. Postoperative collateral formation after indirect bypass for hemorrhagic moyamoya disease.

21. Clinical Features and Surgical Outcomes of Patients With Moyamoya Disease and the Homozygous RNF213 p.R4810K Variant.

22. Abnormal Embryonic Development of Cerebral Arteries as a Potential Cause of Moyamoya Disease.

23. Revascularization Surgery in Patients with Ischemic-Type Moyamoya Disease: Predictors for Postoperative Stroke and Long-Term Outcomes.

24. Association between p.R4810K Variant and Postoperative Collateral Formation in Patients with Moyamoya Disease.

25. Adolescents with moyamoya disease: clinical features, surgical treatment and long-term outcomes.

26. Altered expression of circular RNAs in Moyamoya disease.

27. Clinical Features of Hemorrhagic Moyamoya Disease in China.

28. Transient Ischemic Attack in Pediatric Patients With Moyamoya Disease: Clinical Features, Natural History, and Predictors of Stroke.

29. Steroid sulfatase and filaggrin mutations in a boy with severe ichthyosis, elevated serum IgE level and moyamoya syndrome.

30. Long-Term Outcome After Conservative Treatment and Direct Bypass Surgery of Moyamoya Disease at Late Suzuki Stage.

31. Ischemic Stroke in Young Adults with Moyamoya Disease: Prognostic Factors for Stroke Recurrence and Functional Outcome after Revascularization.

32. Clinical Features, Surgical Treatment, and Long-Term Outcome in Elderly Patients with Moyamoya Disease.

33. Posterior Circulation Moyamoya Disease versus Primitive Vertebral-Basilar Artery System Moyamoya Disease: New Classification of Moyamoya Disease from the Perspective of Embryology.

34. More Precise Imaging Analysis and Diagnosis of Moyamoya Disease and Moyamoya Syndrome Using High-Resolution Magnetic Resonance Imaging.

35. Long Noncoding RNAs and Their Regulatory Network: Potential Therapeutic Targets for Adult Moyamoya Disease.

36. Clinical and Angiographic Features of Patients with Moyamoya Disease and the p.R4810K Heterozygous Variant.

37. Multi-delay arterial spin labeling perfusion MRI in moyamoya disease-comparison with CT perfusion imaging.

38. Delayed Anastomotic Occlusion after Direct Revascularization in Adult Hemorrhagic Moyamoya Disease.

39. Characteristics of cognitive impairment in adult asymptomatic moyamoya disease.

40. Different subtypes of collateral vessels in hemorrhagic moyamoya disease with p.R4810K variant.

41. Association between white matter impairment and cognitive dysfunction in patients with ischemic Moyamoya disease.

42. The Association of the RNF213 p.R4810K Polymorphism with Quasi-Moyamoya Disease and a Review of the Pertinent Literature.

Catalog

Books, media, physical & digital resources